Kirkland & Ellis advised Patient Square Capital, a dedicated health care investment firm, on its Series B investment in Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. The $100 million financing round was led by Patient Square Capital and also included participation from new investors and existing institutional investors. The financing, which closed today, will support Kriya Therapeutic’s mission of transforming the design, development and manufacturing of gene therapies.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
